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9-cis RAIt is well known that the vitamin A metabolite, retinoic acid, plays an important role in vertebrate
development and regeneration. We have previously shown that the effects of RA in mediating neurite
outgrowth, are conserved between vertebrates and invertebrates (Dmetrichuk et al., 2005, 2006) and that RA
can induce growth cone turning in regenerating molluscan neurons (Farrar et al., 2009). In this study, we
have cloned a retinoid receptor from the mollusc Lymnaea stagnalis (LymRXR) that shares about 80% amino
acid identity with the vertebrate RXRα. We demonstrate using Western blot analysis that the LymRXR is
present in the developing Lymnaea embryo and that treatment of embryos with the putative RXR ligand, 9-
cis RA, or a RXR pan-agonist, PA024, signiﬁcantly disrupts embryogenesis. We also demonstrate cytoplasmic
localization of LymRXR in adult central neurons, with a strong localization in the neuritic (or axonal)
domains. Using regenerating cultured motor neurons, we show that LymRXR is also present in the growth
cones and that application of a RXR pan-agonist produces growth cone turning in isolated neurites (in the
absence of the cell body and nucleus). These data support a role for RXR in growth cone guidance and are the
ﬁrst studies to suggest a nongenomic action for RXR in the nervous system.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Retinoic acid (RA) is the active metabolite of vitamin A and is well
known to inﬂuence morphogenesis during vertebrate development
(Maden and Hind, 2003; Maden, 2007). It can also act as a trophic
factor and has been implicated in neurite outgrowth (Corcoran et al.,
2000; Maden et al., 1998; Wuarin et al., 1990) and regeneration
(Dmetrichuk et al., 2005) of the nervous system. Retinoic acid
classically acts through nuclear receptors that act as transcription
factors to affect downstream activation of various genes, including
neurotrophins, cytokines, cell surface molecules (reviewed in Gudas,
1994; Mey and McCaffery, 2004), as well as speciﬁc genes involved in
neurite outgrowth, such as NEDD9 (Knutson and Clagett-Dame, 2008)
and neuron navigator 2 (Muley et al., 2008). The nuclear receptors
responsive to RA include the retinoic acid receptors (RARs) and the
retinoid X receptors (RXRs), and at least three classes of each have
been identiﬁed (α, β, and γ). RARs bind both all-trans and 9-cis RA
isomers, whereas the RXRs (at least in vertebrates) bind only 9-cis RA
(Heyman et al., 1992). There is evidence that both RARs and RXRs play
a role in neurite outgrowth and/or neurite regeneration; RARβ plays a
major role in the induction of neurite outgrowth from both embryonic
(Corcoran et al., 2000) and adult (Dmetrichuk et al., 2005) spinal cord
neurons, while RXR has been suggested to play a role in motor neuroninnervation of limbs in mice (Solomin et al., 1998). Both RARs and
RXRs are found in vertebrate nervous systems, but until recently, it
was generally believed that nonchordates possessed only RXRs.
However, evidence for putative RARs has now emerged from EST/
genomic databases in annelids and molluscs (Albalat and Canestro,
2009), and a molluscan RAR has now been cloned (Carter and
Spencer, 2009; accession no. GU932671).
It has become increasingly evident that many effects of retinoic
acid are conserved between vertebrate and invertebrate species. The
presence of RA in invertebrates has been implicated by the presence of
retinoic acid binding proteins in the insect (Mansﬁeld et al., 1998),
shrimp (Gu et al., 2002), andmarine sponge (Biesalski et al., 1992). RA
has also been detected in ﬁddler crab limb blastemas (Chung et al.,
1998) and in the locust embryo (Nowickyj et al., 2008), suggesting a
role in both limb regeneration and embryonic development. More
recently, we have shown for the ﬁrst time that RA is present in the
invertebrate CNS (Dmetrichuk et al., 2008) and demonstrated that (in
the absence of other neurotrophic factors) it induces neurite
outgrowth as well as growth cone turning in cultured neurons of
the mollusc, Lymnaea stagnalis (Dmetrichuk et al., 2006, 2008; Farrar
et al., 2009). The mechanisms underlying the neurotrophic and
chemotropic effects of retinoic acid in Lymnaea are, at present, largely
unknown, although we have recently shown that the RA-induced
growth cone turning involves a nongenomic mechanism that requires
protein synthesis and calcium inﬂux (Farrar et al., 2009).
In this study, we have cloned a RXR from the CNS of Lymnaea that
demonstrates a high sequence homology with the vertebrate RXRα.
125C.J. Carter et al. / Developmental Biology 343 (2010) 124–137Our aimwas then to determine whether this Lymnaea RXR plays a role
in either embryonic development and/or neuronal regeneration of
central neurons in L. stagnalis.
Materials and methods
Cloning of L. stagnalis RXR
L. stagnalis used in this study were laboratory-bred and kept in
aerated, artiﬁcial pond water and fed lettuce and NutraFin Max
Spirulina ﬁsh food (Hagen). RT–PCR was performed on cDNA
generated from total RNA extracted from the Lymnaea CNS. Brieﬂy,
reverse transcription was carried out with a mixture of poly A and
random hexamer primers according to the iScript cDNA synthesis kit
(BioRad). cDNA was then ampliﬁed with 40 pmol of forward (5′-CGA
CAA AAG ACA GAG AAA CAG ATG YCA RTA YTG-3′) and reverse (5′-
GTC TCT GAA GTG TGG GAT TCT TTT NGC CCA YTC-3′) degenerate
primers. After 3 min of denaturation at 95 °C, 35 cycles at 95 °C for
30 sec, annealing at 55 °C for 30 sec, and elongation at 72 °C for 1 min
were performed with an Eppendorf Mastercycler Personal Thermo-
cycler. Analysis of the product was carried out on 1% agarose gels in
TAE buffer stainedwith ethidium bromide. Fragments of interest were
excised from the gel and cloned into the pGemTEasy vector system
(Promega). Sequencing was performed by GénomeQuébec (Montréal,
Canada) using 3730xl DNA Analyzer systems from Applied Biosys-
tems. Full-length cDNA was obtained by performing multiple rounds
of 5′ and 3′ RACE with cDNA prepared from the same Lymnaea CNS
preparations with the SMART RACE cDNA ampliﬁcation kit
(Clontech).
Antibodies
We designed antibodies against a synthetic peptide from the
predicted ‘hinge’ region of the Lymnaea RXR covering the amino acid
residues 183–198 between the DNA binding domain (DBD) and ligand
binding domain (LBD). This custom-made LymRXR antibody was
produced in New Zealand white rabbits and afﬁnity-puriﬁed from the
antisera by Paciﬁc Immunology Corp. (Ramone, CA, USA). In some
Western blotting procedures, a commercial antibody against human
GAPDH (Abcam Inc.) was used as a cytosolic fraction marker, and a
commercial antibody against human actin (Sigma-Aldrich) was used
as a control.
Lymnaea embryos
To investigate LymRXR protein levels during Lymnaea develop-
ment, egg masses were ﬁrst incubated in pond water at room
temperature and allowed to reach various stages of development, as
described in Nagy and Elekes (2000). These stages included day 0 of
embryogenesis (when egg mass is ﬁrst laid and before ﬁrst cleavage),
the trochophore stage (approx. 36–60 h of embryogenesis), the veliger
stage (approx. 60–96 h of embryogenesis), the adult-like stage just
before hatching (96–192 h of embryogenesis), and hatchlings. When
the embryos reached the desired stage, the capsules were removed
from their gelatinous surroundings, total protein was extracted, and
Western blotting was performed according to the protocol listed
below for adult CNSs. These experiments were performed twice.
To determine if LymRXR plays a role in Lymnaea development,
embryos were incubated in a synthetic RXR agonist (PA024, a kind gift
from Dr. H. Kagechika, Tokyo) and 9-cis RA (Sigma-Aldrich). At day 0 of
embryogenesis (when eggmass isﬁrst laid), capsuleswere teasedout of
the gelatinous surroundings in which they were embedded and
maintained in pond water at room temperature for 30 h (until the
end of the gastrulation stage). This separation of the capsules increased
probability of penetration of the agonist PA024 and 9-cis RA while still
allowing normal development of the egg inside the capsule (Creton etal., 1993). The RXR agonist PA024 (10−7 M), 9-cis RA (10−7 M), or
DMSO (0.001%, vehicle control) was added to separate dishes of
embryos at 30 h of embryogenesis (this was previously shown to be the
most sensitive stage todisruptionbyRA; Creton et al., 1993).Atdays 6–7
of embryogenesis, embryos showing eye and/or shellmalformations, or
arrested development at the trochophore stage, were scored and
compared with the DMSO control embryos. These experiments were
also performed twice with incubation of embryos in RXR antagonists
alone (PA452=10−6 M and HX531=10−6 M both a kind gift from Dr.
H. Kagechika, Tokyo) in the exact same manner as described above.
Statistical analysis was composed of multiple Fisher exact tests that
were then Bonferroni–Holm-corrected.
Western blotting
To investigate the expression of LymRXR protein, the adult
Lymnaea CNS (or whole embryos) were homogenized in lysis buffer
containing 150 mM NaCl, 50 mM Tris–HCl (pH 7.5), 10 mM EDTA, 1%
Trition X-100, 1 mM PMSF, and 0.01% Protease Inhibitor Cocktail
(Sigma-Aldrich) with a PowerGen handheld homogenizer (Fisher
Scientiﬁc). The homogenates were centrifuged 20,000×g at 4 °C for
30 min. Fifteen micrograms of protein from each extract was
separated on a discontinuous SDS–polyacrylamide gel (12% resolving
and 4% stacking) and electroblotted onto a nitrocellulose membrane
(BioRad). For embryo experiments, gels were electrophoresed in
duplicate under identical conditions; one was stained with Coomassie
blue to ensure equal loading of protein and the other was subjected to
Western blot analysis. The membranes were washed for 5 min in 1×
PBS and then blocked in 1× PBS/0.1% Tween-20 (PBT) with 3% skim
milk powder (wt./vol.) for 1 h. The membranes were then incubated
with afﬁnity puriﬁed Lymnaea RXR antibody at a dilution of 1:2500 in
PBT/3% skim milk overnight at 4 °C with gentle horizontal shaking.
This was followed by 4×5 min washes at room temperature in PBT
and incubation with a 1:15,000 dilution of Alexa Fluor 680 goat
antirabbit secondary antibody (Invitrogen). After 4×5 min washes in
PBT and onewash in 1× PBS, themembranes were imagedwith the LI-
COR Odyssey Infrared Imaging System at a wavelength of 700 nm.
To investigate the subcellular expression of LymRXR in the Lymnaea
CNS, as well as in embryos just before hatching, total proteins from the
cytoplasmic, membrane, and nuclear compartments were isolated
according to directions from the Qproteome Cell Compartment kit
(Qiagen). These protein fractions were loaded onto a discontinuous
SDS–polyacrylamidegel, and LymRXRwasdetected byWestern blotting
technique as previously described above. Anti-GAPDH(Abcam Inc.)was
used as a cytosolic fraction marker, and successful isolation of protein
from all three compartments of the CNS was conﬁrmed by staining for
actin. These experiments were performed twice for embryos and four
times for the adult CNS.
Immunostaining
For immunostaining, the CNSs isolated from the snails were ﬁxed
in 4% paraformaldehyde in PBS at 4 °C overnight and washed in 10%
sucrose/PBS for 2 h, 20% sucrose/PBS for 2 h, and then 30% sucrose/
PBS overnight at 4 °C. After embedding the ﬁxed CNSs in Optimal
Cutting Temperature (OCT) Compound (Tissue-Tek), serial 20 µm
sections were cut using a cryostat (Leica Microsystems) and placed on
SuperFrost Plus slides (Fisher Scientiﬁc). For immunostaining of
cultured neurons following outgrowth (24–36 h), cells were ﬁxed in
4% paraformaldehyde in PBS at 4 °C overnight. From this point on, all
immunostaining procedures were the same for CNSs and cultured
neurons. The samples were washed in PBS and then permeabilized in
0.3% Triton X-100 in PBS (PBT) for 20 min and blocked in 5% normal
goat serum (NGS) in PBT for 1 h at room temperature. The samples
were then incubated with the primary LymRXR antibody diluted
1:100 in blocking solution at 4 °C overnight. As a control, preparations
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antibody, at 4 °C overnight. All samples were then washed in PBT
3×5 min and incubated in 1:500 dilution of Alexa Fluor 488 goat
antirabbit secondary antibody (Invitrogen) in blocking buffer at room
temperature for 2 h. The samples were washed in 3×5 min in PBT and
counterstained with DAPI for 2 min to visualize the nuclei. After a
brief wash in PBS, the specimens were coverslipped with antifade
Fluorosave mounting media (Calbiochem).
Cell culture procedures
All cell culture procedures were performed as described previously
(Dmetrichuk et al., 2006; Farrar et al., 2009; Ridgway et al., 1991).
Brieﬂy, under sterile conditions, the central ring ganglia were isolated,
subjected to a number of antibiotic washes and enzymatic treatment,
and then pinned down in a dissection dish and bathed in high
osmolarity (L-15 derived) deﬁned medium (DM; Ridgway et al.,
1991). Using a pair of ﬁne forceps, the connective tissue sheath
surrounding the ganglia was removed, and identiﬁed Pedal A (PeA)
motor neuronswere individually extracted using gentle suction applied
via a ﬁre-polished pipette attached to a microsyringe. The individually
identiﬁed PeA somata were plated directly on poly-L-lysine-coated
dishes (onto a glass coverslip) containing brain-conditioned medium
(CM;Wonget al., 1981) and atRA(10−7 M) to promote outgrowth. Cells
weremaintained in the dark at 22 °C overnight. An invertedmicroscope
(Zeiss Axiovert 200) was used for all phase and ﬂuorescent imaging of
cultured cells.
Growth cone assays
Growth cone assays were performed in an identical manner to
those described in detail elsewhere (Farrar et al., 2009). Brieﬂy, a
pressure pipette (Eppendorf-Femtojet; 4–8 µm) containing 9-cis RA
(10−5 M), or the RXR agonist, PA024 (10−5 M or 10−6 M), was
positioned 50 to 100 µm from an actively growing growth cone.
Pressures between 5 and 12 hPa were used to apply the agonists,
while holding pressures of 1–2 hPa were used during rest periods
to prevent backﬂow of bath solution. Concentrations detected at
the growth cone were likely 100–1000 times less than those
present in the pipette (Lohof et al., 1992). Control experiments
using the DMSO vehicle solution for the agonist (0.1%) were
performed in the exact same manner. For isolated growth cone
experiments, neurites were mechanically separated from the cell
body using a sharp glass electrode (Farrar et al., 2009). To test
whether the RXR agonist-induced turning was inhibited in the
presence of RXR antagonists, PA024 was applied to the growth
cones, either in the presence of bath-applied DMSO vehicle control
(ﬁnal bath concentration of 0.01%) or in the presence of the RXR
antagonist PA452 (ﬁnal bath concentration of 10−6 M) or HX531
(ﬁnal bath concentration of 10−6 M).
Growth cone behaviour in both intact and isolated neurites in
response to drug application was monitored for at least 1 h, and the
maximum turning angle was recorded. A one-way analysis of variance
(1-way ANOVA) was performed on growth cone data sets, and a
Tukey–Kramer post hoc test was used to determine statistical
signiﬁcance. Results are expressed as mean±standard error of the
mean (SEM) and are deemed signiﬁcant when Pb0.05.
Results
Sequencing of LymRXR
Using RT–PCRwith degenerate primers designed from other known
RXR sequences,we obtained an initial cDNA fragment from the CNS of L.
stagnalis. A full-length RXR cDNA was elucidated by multiple rounds of
5′ and3′RACE from the initial cDNA clone. Theﬁnal full-length cDNAweobtained was 1593 bp, with a 1308 bp major open reading frame that
encodes for a 436 aa RXR protein (we termed LymRXR; accession no.
AY846875). This LymRXR has an overall amino acid identity of 97%with
the RXR from a closely related mollusc, Biomphalaria glabrata (BgRXR;
accession no. AAL86461). Of the various vertebrate RXR subtypes,
LymRXR is most similar to the RXRα subtype. The predicted DNA-
bindingdomain (DBD) of LymRXR shares∼89% amino acid identitywith
the Rattus norvegicus RXRα (accession no. NP_036937), while the
predicted ligand-binding domain (LBD) shares ∼81% amino acid
identity with rat RXRα (Fig. 1).
LymRXR in the developing embryo
RA, acting as a transcriptional activator, is well known to play a
role in vertebrate development. Our ﬁrst aim following the identiﬁ-
cation of LymRXRwas thus to determinewhether the RXR proteinwas
present in the developing Lymnaea embryo. Lymnaea embryogenesis
is intracapsular, lasting about 8 days in total. There are three major
developmental stages, deﬁned as the trochophore stage (approx. 36–
60 h of embryogenesis), veliger stage (60–96 h of embryogenesis),
and the postmetamorphic stage (96 h to hatching). It is during the
veliger stage where ganglia are ﬁrst detected (Nagy and Elekes, 2000)
and many of the organs begin to develop (Meshcheryakov, 1972).
Following hatching at about 8 days, the animal starts its juvenile, free-
living existence.
A custom-made antibody against a synthetic peptide from the
‘hinge’ region between the DBD and LBD was used to detect the
LymRXR protein during the various stages of embryogenesis. Western
blot analysis of Lymnaea embryo total protein revealed a band of
approximately 47 kDa in size, close to the predicted molecular weight
of 48 kDa (Fig. 2A). LymRXR protein was present as early as the
trochophore stage (approx. 36–60 h) and was present in all
subsequent stages studied, with its expression appearing maximal
at the hatchling stage (Fig. 2A). RXR is typically known for its role as a
nuclear hormone receptor and transcription factor. Thus, to determine
its nuclear localization in cells of the Lymnaea embryo, total protein
fractionswere isolated from the cytoplasm,membrane, and nucleus of
embryos, immediately before hatching, using a Qproteome Cell
Compartment kit (Qiagen). Western blot analysis showed a positive
signal for RXR not only in the nuclear compartment of embryos but
also in the cytoplasmic and membrane compartments (Fig. 2B).
It is well documented that disruptions of RA signaling in vertebrates,
either by inhibition of its synthesis or by exogenous addition of RA, can
lead to a wide array of developmental defects in limb, CNS, and main
body axis formation (Durston et al., 1989; Sive et al., 1990; Stratford
et al., 1996). Creton et al. (1993) have also previously shown that RA
disrupted embryogenesis in Lymnaea, mainly by affecting eye and shell
development. Having determined that RXR is present in the embryo,we
next aimed to determine whether known RXR agonists/ligands would
disrupt the normal pattern of development in Lymnaea. We also used
eye and shell formation as indicators of normal growth because these
are easily visualized and characterized using light microscopy, shortly
after the veliger stage. Eyes normally become pigmented at the end of
the veliger stage (at about 96 h), and the shell extends over the visceral
masses just a few hours later (Nagy and Elekes, 2000).
Lymnaea embryos weremaintained within their capsules but were
removed from their gelatinous surroundings. Capsuled embryos were
treated with a synthetic RXR pan-agonist, PA024 (10−7 M; n=40),
the putative RXR ligand, 9-cis RA (10−7 M; n=40), and DMSO as the
vehicle control (0.001%; n=40). These treatments were started at the
gastrula stage (30 h) and continued for the next 5 days of embryonic
development. In the presence of DMSO, both shell (Fig. 2C) and eye
(Figs. 2C and Di) development appeared normal. However, we found
that treatments with 9-cis RA and PA024 produced defects in both eye
(Figs. 2Dii–iii and G) and shell formation (Figs. 2E and H) in a
signiﬁcant number of embryos. Eye defects included either missing
Fig. 1. The Lymnaea RXR sequence. Multiple sequence alignment of the Lymnaea stagnalis RXR (LymRXR; accession no. AY846875), Biomphalaria glabrata RXR (BgRXR; accession no.
AAL86461), Rattus norvegicus RXR alpha (RatRXRalpha; accession no. NP_036937), and the amphioxus Branchiostoma ﬂoridae RXR (AmphiRXR; accession no. AAM46151) proteins.
Note the high conservation of amino acids in the DNA-binding domain (DBD) and the ligand-binding domain (LBD). Amino acid residues reported to interact with the RXR natural
ligand 9-cis RA (Egea et al., 2000) are indicated by green circles above the aligned sequences.
127C.J. Carter et al. / Developmental Biology 343 (2010) 124–137eyes (Fig. 2Diii) or those noticeably reduced in size (Fig. 2Dii).
Interestingly, PA024 displayed a higher number of abnormalities than
9-cis RA, including a number of embryos that exhibited halted
development at the trochophore stage (Figs. 2F and J).
Similar experiments were next performed with incubation of
embryos in RXR antagonists to determine the effect of inhibiting RXR
signaling during embryogenesis. Incubation in the RXR antagonist,HX531 (10−6 M), produced shell defects in all embryos (48 of 48
embryos; 100%) but not in eye development (0 of 48 embryos; 0%).
Interestingly, incubation in the RXR antagonist, PA452 (10−6 M), did
not produce any observable defects in either eye or shell development
(0 of 44 embryos; 0%; data not shown).
Together, these data strongly suggest a role for RXR in Lymnaea
development.
Fig. 2. Embryonic RXR plays a role in Lymnaea development. (A) Western blot analysis at ﬁve different stages of Lymnaea embryogenesis revealed its presence as early as the
trochophore stage, and showed maximal expression at hatching. A Coomassie blue stain of the acrylamide gel, before transfer, was used as a loading control. (B) Western blot
analysis performed on subcellular fractionations of embryos, using the LymRXR antibody, showed a signal in the cytoplasmic, membrane and nuclear compartments. Actin staining as
a control also showed staining in all three compartments. (C) DMSO (0.001%) added to the Lymnaea embryos as a vehicle control did not affect development. All of the animals
showed normal eye and shell development (compared to embryos in the absence of DMSO). Green arrows indicate the outline of the normally developed shell, and yellow arrows
indicate the presence of both eyes. Scale bar: 200 μm. (D) (i) Representative image of a control embryo in DMSO showing the clear presence of an eye (yellow arrow).
(ii) Representative example of an underdeveloped eye, reduced in size (yellow arrow), following incubation in the natural RXR ligand, 9-cis RA (10−7 M). (iii) Representative
example of an embryo missing an eye (yellow arrow indicates where eye should be located) following incubation in the synthetic RXR agonist PA024 (10−7 M). Scale bar (Di–iii):
150 μm. (E) Green arrows indicate malformation of the shell following incubation in 9-cis RA (10−7 M). Scale bar: 200 μm. (F) PA024 halted some embryos at the trochophore stage.
Scale bar: 100 μm. For graphs (G) through (J), 9-cis RA (n=40) and PA024 (n=40) treatments were compared to the DMSO (n=40) treatment (⁎Pb0.05, ⁎⁎Pb0.01).
128 C.J. Carter et al. / Developmental Biology 343 (2010) 124–137LymRXR is present in the adult CNS
We have previously shown that both atRA and 9-cis RA exert trophic
and tropic effects on adult CNS neurons of Lymnaea (Dmetrichuk et al.,
2006, 2008), but little is known of the underlying cellular and molecular
mechanisms. We next aimed to determine whether RXR expression is
maintained following the embryonic stages and, speciﬁcally, to determine
whether it is present in the adult (nonregenerating) CNS. Western blotanalysis of adult Lymnaea CNS total protein again revealed a band of
approximately 47 kDa in size (Fig. 3A). Using the same LymRXR-speciﬁc
antibody, we next performed immunohistochemistry on frozen sections
of acutely isolated Lymnaea CNSs (n=30). Immunoreactivity was
detected in neurons of all central ganglia. There was strong immunoreac-
tivity in the neuropil and nerve bundles radiating from the brain,
suggesting staining of the axonal tracts (Figs. 3B and D). Interestingly,
therewas little to no apparent staining of RXR (traditionally considered to
Fig. 3. Cytoplasmic localization of LymRXR in the adult nonregenerating nervous system. (A) Western blot analysis of total protein extracted from the Lymnaea CNS showed a band
near 47 kDa that closely matches the predicted molecular weight of LymRXR from our cloned sequence. (B and C) LymRXR immunoreactivity was detected in the neurons of ganglia
of the CNS (visceral ganglion shown) primarily in the cytoplasm of the cell body (yellow arrow), axons (red arrow), neuropil (blue arrow), and nerve bundles radiating from the
brain (purple arrow). Note the absence of RXR staining in the nuclei stained blue using DAPI (C; white arrow). Scale bars: 100 μm. (D) Some ganglia (right pedal ganglion shown)
produced strong punctuate-like staining near the periphery (white arrow). Scale bar: 50 μm. (E) Control staining was also performed under the same conditions only in the absence
of the primary LymRXR antibody. No immunostaining was visible (inset is a phase-contrast image of the same ganglia). Scale bar: 100 μm. (F) Acutely isolated axons from the
Lymnaea CNS, plated in vitro, also displayed strong immunoreactivity. Inset is a phase-contrast image of the same axon. Scale bar: 30 μm. (G) Western blot performed on subcellular
fractionations using the LymRXR antibody showed a signal in the cytoplasmic (Cyt) and membrane (Mem) compartments but not in the nuclear (Nuc) compartment. (H) GAPDH is
an abundant glycolytic enzyme in cytoplasm, and a GAPDH antibody, used as a control, showed signal only in the cytoplasmic compartment of the same samples. (J) Actin staining
served as a positive control to demonstrate successful isolation of protein from the nuclear compartment.
129C.J. Carter et al. / Developmental Biology 343 (2010) 124–137be a nuclear receptor) in the nuclear region of the neurons, given that
there was no RXR signal overlapping with the nuclear DAPI staining
(Fig. 3C). Someganglia also showedstrongpunctuate-like staining around
the periphery of the ganglia (Fig. 3D), which may have been due to RXR
immunoreactivity of glial networks and cell bodies in the neural sheath.
Control CNS sections with no primary antibody added (n=6) demon-
strated no immunostaining (Fig. 3E).
To conﬁrm the neuritic localization of RXR, immunoﬂuoresence
was also performed on acutely isolated axons. During cell isolation
from the intact ganglia, axonal segments up to ∼200 µm in length can
be acutely isolated, removed from the cell body, and then plated in cell
culture (Spencer et al., 2000). We showed that LymRXR immunos-
taining was indeed present in the acutely isolated axons in culture(n=3 of 3; Fig. 3F), which conﬁrmed the above observation that RXR
is present in the neuritic processes of neurons in the intact, adult CNS.
To further identify the neuronal compartmentalization of LymRXR
in the adult CNSs, we isolated total protein fractions from the
cytoplasm, membrane, and nucleus of the adult Lymnaea CNS using a
Qproteome Cell Compartment kit (Qiagen). In Fig. 3G, Western blot
analysis showed a positive signal for RXR in the cytoplasmic and
membrane compartments but not in the nucleus. Successful isolation
of protein in the nuclear fraction was conﬁrmed by staining for actin,
which is now well known to reside in the nucleus (Fig. 3J; Franke,
2004; Bettinger et al., 2004). Anti-GAPDH was also used as a control
on the same protein fractions, and as expected, GAPDH showed only
positive immunoreactivity in the cytoplasmic compartment (Fig. 3H).
130 C.J. Carter et al. / Developmental Biology 343 (2010) 124–137To further conﬁrm the absence of nuclear RXR in the adult CNS cellular
fractions, two additional CNS samples were again run, but this time in
parallel with embryonic tissue. In the CNS fractions, the RXR was
present in both cytoplasmic and membrane compartments but was
again absent in the nuclear compartment (data not shown), whereas
the embryonic fractions revealed nuclear RXR (as seen in Fig. 2B).
LymRXR is present in the neurites and growth cones of regenerating
cultured neurons
Retinoic acid is known to promote neurite regeneration in many
species, including neurons from Lymnaea (Dmetrichuk et al., 2006,
2008). Our next aim was to determine the localization of RXR
immunoﬂuorescence in regenerating central neurons in culture. PeA
motor neurons were individually isolated from the intact ganglia and
given 24–36 h to regenerate in cell culture (Fig. 4Ai). Following
outgrowth, cells were then ﬁxed and stained with the LymRXRFig. 4. LymRXR is present in the neurites and growth cones of regeneratingmotor neurons in
regenerated neurites. (Aii) Immunostaining of the same PeA cell with LymRXR antibody reve
Ai–ii: 50 μm. (Bi) Phase-contrast image of two neurites from the same cell. (Bii) Immunostai
arrows indicate staining of one branch, while the other branch displayed little to no staining
vitro. (Cii) Immunostaining with the LymRXR antibody showed a signal in the neurite leading
the lamellipodia and ﬁlopodia (F). Scale bars Ci–ii: 10 μm.antibody. RXR immunoreactivity was visualized in the cell body of
every cultured PeA neuron, whether it was actively regenerating
neurites or not (n=96 of 96). In the neurons that displayed
outgrowth (n=35), RXR immunoreactivity was observed in the
majority of neurites (Fig. 4Aii), although there appeared to be a
differential distribution of the RXR signal in the neurites of some cells.
Fig. 4Bii illustrates an example of a neurite emanating from a cell body
that displayed strong immunoreactivity over most of its length, while
another neurite from the same cell body showed very little RXR
staining. Furthermore, while most of the growth cones located at the
tips of the neurites demonstrated positive immunoreactivity for RXR
(n=95 of 102), there were some neurites that displayed little, if any,
RXR staining along the neurite leading to the growth cone.
Immunostaining of the RXR was evident in the central or C-domain
of the growth cones, but very little to no staining was evident in the
peripheral or P-domain (lamellipodia and ﬁlopodia; Fig. 4Cii). Control
regenerating PeA neurons, under the same staining conditions exceptvitro. (Ai) Phase-contrast image of a cultured Lymnaea Pedal A neuron at 48 h in CMwith
aled a signal in the cytoplasm of the cell body and the regenerating neurites. Scale bars
ning with the LymRXR antibody showed differential staining in the two branches. White
(red arrow). Scale bars Bi–ii: 20 μm. (Ci) Phase-contrast image of a PeA growth cone in
to the growth cone (X), in the central domain of the growth cone (D), but no staining in
131C.J. Carter et al. / Developmental Biology 343 (2010) 124–137in the absence of primary antibody, did not demonstrate RXR
immunoreactivity (n=6; data not shown).
A RXR agonist induced growth cone turning
We have previously shown that retinoic acid (both all-trans and 9-cis
isomers) can induce positive growth cone turning of regenerating
Lymnaea growth cones (Dmetrichuk et al., 2006, 2008; Farrar et al.,Fig. 5. Intact PeA growth cones turn toward the RXR agonist. (A) (i–ii) Representative exa
application). Approximate pipette location is indicated. Scale bar: 30 μm. (iii) Histogram dep
one growth cone. Positive values represent a turn toward the pipette and negative values rep
cone turning toward the RXR pan-agonist PA024 (i: 0 min, ii: 60 min after start of applicati
cones to PA024, and each bar represents one growth cone. Positive values represent a turn to
Representative example of a PeA growth cone that did not turn toward DMSO (vehicle contro
maximum turning angle of intact growth cones to DMSO, and each bar represents one growth
a turn away from the pipette.2009).Wehave also shown that this growth cone turning is dependent on
protein synthesis and calcium inﬂux (Farrar et al., 2009). Because we had
demonstrated that this turning response occurred in isolated growth
cones and involved a localized, nongenomic mechanism, we had not
previously investigated a role for the retinoid receptor. However, having
nowdetermined that the RXR is present in the regenerating growth cones
and neurites, we next investigated whether it was involved in the
localized growth cone turning response to RA.mple of a PeA growth cone turning toward 9-cis RA (i: 0 min; ii: 27 min after start of
icts maximum turning angle of intact growth cones to 9-cis RA, and each bar represents
resent a turn away from the pipette. (B) (i–ii) Representative example of a PeA growth
on). Scale bar: 30 μm. (iii) Histogram depicts maximum turning angle of intact growth
ward the pipette and negative values represent a turn away from the pipette. (C) (i–ii)
l) (i: 0 min, ii: 26 min after start of application). Scale bar: 30 μm. (iii) Histogram depicts
cone. Positive values represent a turn toward the pipette and negative values represent
Fig. 5 (continued).
132 C.J. Carter et al. / Developmental Biology 343 (2010) 124–137We have previously reported growth cone turning toward 9-cis RA
in VF neurons (Dmetrichuk et al., 2008). However, 9-cis RA was
applied again in this study to directly compare its effects on PeA
growth cone behaviour with those of a RXR agonist. Here, we showed
that 9-cis RA produced attractive growth cone turning of intact PeA
neurites with an average turning angle of 24.8°±7° (n=6; Fig. 5Ai–
iii). We next pressure-applied the RXR pan-agonist PA024 onto the
PeA growth cones to determine whether it would mimic the growth
cone turning induced by 9-cis RA. Indeed, PA024 induced positive
growth cone turning of intact neurites with a mean angle of
30.6°±4.0° (n=14; Fig. 5Bi–iii). As PA024 is dissolved in DMSO,
control experiments with DMSO in the pipette were also performed
and were shown not to produce positive growth cone turning
(−16.9°±8.3°; n=7; Fig. 5Ci–iii). Statistical analysis revealed that
growth cone turning toward the RXR agonist PA024 was signiﬁcantly
different from the DMSO control (Pb0.05) but was not signiﬁcantly
different from growth cone turning toward 9-cis RA.
We previously showed that neurites physically transected and
isolated from their cell body could also turn toward RA, demonstrat-
ing that a local mechanismwas involved.We next aimed to determine
whether the RXR agonist would also induce turning in growth cones
of transected neurites, physically isolated from their cell body. Once
again, PA024 induced attractive growth cone turning (Fig. 6Ai–iv)
with a mean angle of 23.9°±13.8° (n=11; Fig. 6B), which was not
signiﬁcantly different from that produced by PA024 in intact neurites.
All intact and isolated neurite data are summarized in Fig. 6C.The RXR agonist-induced growth cone turning is inhibited in the
presence of an RXR antagonist
We next aimed to determine whether we could block the RXR
agonist-induced growth cone turning in the presence of a RXR
antagonist. First of all, we showed that application of the RXR agonist
PA024 (10−6 M) to intact PeA growth cones in the presence of the
vehicle control (DMSO; 0.01%) produced growth cone turning (Fig. 7Ai–
ii)with ameanangle of 36.3°±8.7° (n=7;Fig. 7B).Wenext applied the
RXR agonist PA024 (10–6 M) in the presence of the RXR antagonistPA452 (ﬁnal bath concentration of 10–6 M). In the presence of the RXR
antagonist PA452, the mean turning angle in response to application of
the agonist was signiﬁcantly reduced to 3.3°±10.3° (n=9; Pb0.05;
Fig. 7E). However, despite the overall reducedmean turning angle, six of
the nine growth cones maintained a positive turn toward the RXR
agonist in the presence of PA452 (Fig. 7Ci–ii), with an average turning
angle of 22.5°±4.0°. The remaining three growth cones turned away
from thepipette (Fig. 7Di–ii),with amean turning angle of−35°±12.3°
(n=3).
We next chose to use a different RXR antagonist, HX531, to
determine whether we could block the agonist-induced growth cone
turning. In these experiments, we recorded the growth cone turning
angle in response to application of the RXR agonist in the presence of
HX531 (10−6 M). This time, the growth cone turning toward PA024was
completely abolished in 9 of the 10 growth cones tested (Fig. 7Fi–ii) The
mean turning angle in the presence of HX531 was−19.4°±7.5° away
from the pipette (Fig. 7G), which was signiﬁcantly different from the
turning angle in DMSO (Pb0.01; Fig. 7H). We also conﬁrmed that the
turning of isolated PeA growth cones toward the RXR agonist was
abolished in the presence of HX531 (n=4 of 4; data not shown).
In summary, these data suggest that RXR, located in neurites and
growth cones of regenerating neurons, plays a novel, nongenomic role
in RA-induced growth cone turning, at least in Lymnaea PeA motor
neurons.Discussion
In this study, we have cloned a full-length RXR from the mollusc, L.
stagnalis and have shown that this retinoid receptor is present in the
developing embryo, aswell as in the nonregenerating, adult CNS,where it
was found in the neuritic domains of central neurons. Using regenerating
culturedmotor neurons, we have provided evidence that it plays a role in
the chemotropic response of growth cones to retinoic acid.
RXRs are highly conserved members of the steroid/retinoid family
of nuclear hormone receptors and have been identiﬁed in species
ranging from the phylogenetically oldest metazoan phylum (the
sponge) to mammals (Mangelsdorf et al., 1992). Interestingly, the
Fig. 6. Isolated PeA growth cones turn toward the RXR agonist. Neurites were physically isolated from the cell bodies and the RXR agonist PA024 was applied to the isolated growth
cones. (A) Representative example of an isolated growth cone turning toward PA024 (i) before PA024 application and following (ii) 8 min, (iii) 17 min, and (iv) 30 min of PA024
application. Scale bar: 25 μm. (B) Histogram depicts maximum turning angle of isolated growth cones to PA024, and each bar represents one growth cone. Positive values represent a
turn toward the pipette and negative values represent a turn away from the pipette. (C) Summary graph of mean growth cone turning angles under all conditions. Error bars
represent standard error of the mean (SEM). ⁎Pb0.05 when compared to DMSO controls.
133C.J. Carter et al. / Developmental Biology 343 (2010) 124–137RXR from Lymnaea (a lophotrochozoan, nonchordatemollusc and true
invertebrate outside of the chordate lineage) shows higher amino acid
identity with the rat RXRα than the RXR from Polyandrocarpa, a
urochordate species and closest living relative of the vertebrates
(Borel et al., 2009). Furthermore, it has previously been shown that a
molluscan RXR (from B. glabrata; BgRXR) functionally interacts with
vertebrate RXR-binding partners, strongly suggesting that retinoid
signalling may be shared between the lophotrochozoan branch of theprotostomes and the deuterostomes (which contain the chordate
branch).
RXRs from mammals have been studied most extensively, and it
has been shown that they can form homodimers, heterodimers, or
even homotetramers and regulate target gene expression when
bound with their proposed ligand, 9-cis RA (Kersten et al., 1995).
Interestingly, the amino acids in mouse RXRα that interacted with 9-
cis RA (Egea et al., 2000) are all perfectly conserved in the BgRXR
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135C.J. Carter et al. / Developmental Biology 343 (2010) 124–137sequence (Bouton et al., 2005) as well as in our LymRXR sequence. The
BgRXR can also transactivate transcription when treated with
exogenous 9-cis RA (Bouton et al., 2005). Although there is evidence
that invertebrate RXRs, like the vertebrate RXRs, bind 9-cis RA
(Kostrouch et al., 1998), a recent study showed that both 9-cis and all-
trans RA isomers bind with similar afﬁnities to the locust RXR
(Nowickyj et al., 2008). All-trans RA also upregulates RXRmRNA in the
marine sponge Suberites domuncula (Wiens et al., 2003) and increases
the abundance of RXRmRNA in blastemas during limb regeneration in
the ﬁddler crab Uca pugilator (Chung et al., 1998). We have recently
shown using HPLC and MS that both 9-cis and all-trans RA isomers are
present in the Lymnaea CNS (Dmetrichuk et al., 2008), and so we
cannot rule out that both isomers may be natural ligands for LymRXR.
RXR expression in the developing embryo
Our results indicate that RXR expression occurred in Lymnaea
embryos as early as the trochophore stage and continued through the
postmetamorphic stage, reaching maximal expression at hatching
(juvenile form). We do not knowwhether this expression occurred in
the nervous system or whether it was associated with other organs.
However, demonstration of RXR expression at the veliger stage
correlates with the ﬁrst ultrastructural detection of cerebral and pedal
ganglia (Nagy and Elekes, 2000). However, at this developmental
stage, the authors detected only two to three cells per ganglia, and
only a small number of axon proﬁles, with no evidence of ﬁlopodial
processes or developing synapses. In the later stages of embryonic
development (postmetamorphic, adult-like stage), when we ob-
served increased RXR expression, Nagy and Elekes (2000) observed
the whole central ring ganglia and neuropil densely packed with axon
proﬁles, although there was no evidence of glia or the neural sheath.
Interestingly, the authors proposed that the absence of the neural
sheath during these stages would facilitate trophic and/or hormonal
inﬂuences in the developing ganglia, which we propose may include
trophic or tropic support provided by RA. By hatching, at which stage
we saw maximal RXR expression, Nagy and Elekes (2000) demon-
strated that the CNS had signiﬁcantly increased in size, with enlarged
neuropil and more axon proﬁles, as well as the ﬁrst evidence of glia
and a neuronal sheath. In summary, we found that RXR is expressed in
our Lymnaea embryos before the metamorphic stage, which is
thought to be the time when the neuropil is undergoing substantial
reorganization, likely indicating a period of substantial migration and
reorganization of axons (Nagy and Elekes, 2000). It is quite feasible,
therefore, that the RXR plays a role in Lymnaea nervous system
development.
Creton et al. (1993) have previously demonstrated that application
of 10−7 M RA during the gastrulation stage of Lymnaea embryos
produced only eye defects (no shell or CNS deformations) and only in
15% of embryos. In our study, both eye and shell deformations were
found following incubation in 10−7 M 9-cis RA and PA024. Although
not explicitly stated, we presume that the isomer used in the previous
studies was atRA, possibly explaining the difference in teratogenicity
observed. If this is indeed the case, it might suggest that 9-cis RA is a
more potent teratogen in Lymnaea than atRA. It should be noted,
however, that in vertebrates, 9-cis RA activates RARs, in addition toFig. 7. The agonist-induced growth cone turning is inhibited by RXR antagonists. The RXR ago
of either DMSO (vehicle) or RXR antagonists in the bath. (A) An example of a growth cone th
(i) Before application of PA024 and (ii) following 29 min of application. Note that the growth
depicts turning angles of intact growth cones to PA024 in the presence of DMSO, and each ba
toward PA024 in the presence of bath-applied RXR antagonist, PA452 (10−6 M). (i) Bef
(D) Representative example of a growth cone that turned away from PA024 in the presence
(ii) following 14 min of application. Scale bar: 30 μm. (E) Histogram depicts turning angles o
(F) Representative example of a growth cone that turned away from PA024 in the presence
(ii) following 49 min of application. Scale bar: 30 μm. (G) Histogram depicts turning angle
Summary graph of mean growth cone turning angles in response to PA042 in the presence of
⁎Pb0.05 and ⁎⁎Pb0.01, when compared to DMSO controls.RXRs. It is thus possible that 9-cis RA will also be activating a RAR. We
believe this unlikely, as despite our recent cloning of an RAR in
Lymnaea, we have not yet been able to detect the protein in the early
embryonic stages of development (Carter and Spencer, 2009). This
suggests that if the RAR is indeed present, it is likely at much lower
levels than the RXR. In support of our hypothesis that 9-cis RA is likely
acting via the RXR, the effects of 9-cis RA were closely mimicked by
PA024, which was developed as a RXR-selective agonist (Ohta et al.,
2000). The demonstration that the RXR was present in the nuclear
compartments of embryonic protein fractions strongly suggests that
the teratogenic effects of the RXR agonist and 9-cis RA were likely
mediated via genomic actions of the RXR. However, wewere unable to
distinguish cellular localization of the RXR in speciﬁc tissues of the
embryo, and as its presence was also shown in cytoplasmic and
membrane compartments, we cannot rule out the possibility of
nongenomic effects during embryogenesis.
Cytoplasmic localization of RXR and its role in growth cone turning
behaviour
Although we could not determine where in the Lymnaea embryo
the RXR was speciﬁcally expressed, we were able to clearly determine
the expression and subcellular localization of RXR in neurons of the
adult CNS. We found that LymRXR protein was localized to the
cytoplasm and membrane of adult neurons, and staining in the
neuropil strongly suggested localization in the axonal tracts. This
axonal staining was further conﬁrmed following immunostaining of
acutely isolated axonal segments from the CNS, plated in culture.
These ﬁndings were interesting because RXR traditionally acts as a
ligand-activated transcription factor and would thus be expected to
show nuclear localization. Some nuclear receptors including steroid
and thyroid hormone receptors can, however, shuttle between the
nucleus and the cytoplasm (DeFranco, 1997; Kaffman and O'Shea,
1999). RXRα also shuttles between the nucleus and cytoplasm (either
in the absence or presence of its ligand 9-cis RA) and can also act as a
shuttle for the orphan receptor TR3, a process stimulated by 9-cis
RA (Lin et al., 2004). 9-cis RA was also found to enhance nuclear
translocation of RXRα in COS-7 cells by associating with importinβ
bound to a RXRα nuclear localization signal (NLS). Phosphorylation
of a conserved serine/threonine in the NLS of nuclear receptors
inhibits their ability to translocate to the nucleus, and if threonine is
mutated into aspartic acid in human RXRα, nuclear localization is
signiﬁcantly hindered (Sun et al., 2007). Our LymRXR protein shares
an identical NLS with the human RXRα, suggesting that phosphor-
ylation of this threonine in LymRXR may play a role in its cytoplasmic
localization.
In embryonic cultured rat hippocampal neurons, RXR isoforms
exhibited differential nuclear and cytoplasmic staining. All RXR
isoforms except RXRβ2 were shown to be present in the cytoplasm,
but RXRαwas the only RXR isoform that was expressed in the axonal
compartment (Calderon and Kim, 2007). RXRα was also evident in
the axonal compartment of newly regenerating axons following
sciatic nerve crush injury (Zhelyaznik and Mey, 2006), possibly
supporting a role for RXR in neural regeneration. In our regenerating
adult Lymnaea neurons, RXR immunoreactivity was found in most ofnist, PA042, was pressure-applied (10−6 M) to intact PeA growth cones in the presence
at turned toward the RXR agonist PA024 in the presence of bath-applied DMSO (0.01%).
cone continued to grow in the direction of the pipette. Scale bar: 30 μm. (B) Histogram
r represents one growth cone. (C) Representative example of a growth cone that turned
ore application of PA024 and (ii) following 35 min of application. Scale bar: 30 μm.
of bath-applied RXR antagonist, PA452 (10−6 M). (i) Before application of PA024 and
f intact growth cones in response to PA024 in the presence of the RXR antagonist PA452.
of bath-applied RXR antagonist, HX531 (10−6 M). (i) Before application of PA042 and
s of intact growth cones to PA024 in the presence of the RXR antagonist HX531. (H)
either DMSO or RXR antagonists. Error bars represent standard error of themean (SEM).
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between neurites of the same cell was observed. The cellular
distribution of RXRα has been shown to be time-dependent after
contusion injury of rat spinal cord, varying between dendritic and
nuclear localization, depending on days following surgery (Schrage et
al., 2006). Interestingly, these authors also determined the presence of
retinoid receptors in the cytoplasm of neurons and glia cells in the
noninjured spinal cord similar to our observations of LymRXR
distribution in the nonregenerating CNSs.
Having demonstrated neuritic localization of LymRXR, both in
nonregenerating and regenerating neurons, we next demonstrated
that a RXR pan-agonist, applied to the growth cones of cultured PeA
motor neurons, induced growth cone turning and mimicked the
growth cone response to 9-cis RA (and all-trans RA seen previously;
Dmetrichuk et al., 2008). We should note, however, that this RXR pan-
agonist was designed for the vertebrate RXR, and we have no
knowledge of its binding afﬁnity to the LymRXR (although our LymRXR
shows N80% homology to the LBD of vertebrate RXRα and the 9-cis RA-
interacting amino acids are 100% conserved). Likewise, both RXR
antagonists used in this study were designed against the vertebrate
RXR, yet our data show that both antagonists signiﬁcantly reduced the
growth cone turning response to the RXR agonist. Interestingly, the
results with the RXR antagonist PA452 were more ambiguous than
with the antagonist HX531. In the presence of PA452, although the
overall mean turning angle was signiﬁcantly reduced compared to
controls, the RXR agonist was still able to induce a positive turning
response in six of the nine growth cones tested. This was not the case
with HX531, where only 1 of 10 growth cones showed any positive
turning response to the RXR agonist. In 9 of the 10 growth cones, the
attractive turning was completely abolished in HX531. It appears,
therefore, that HX531 is a more effective antagonist for the LymRXR
than PA452, although the reason for this is not known. This is also
supported by our ﬁnding that HX531 produced some teratogenic
effects during Lymnaea embryogenesis, whereas PA452 had no
obvious effect.
Together with our evidence that LymRXR is localized in neurites
and growth cones, our data showing RXR agonist-induced growth
cone turning (that is subsequently inhibited in the presence of a RXR
antagonist) strongly implicate a role for RXR in regeneration and
growth cone guidance. In support of this conclusion, Zhelyaznik and
Mey (2006) recently showed that RXRα transcript and protein levels
were upregulated after sciatic nerve crush injury in rats. Furthermore,
they demonstrated that the increase in RXRα immunoreactivity after
injury did not occur in the degenerating nerve stump but was
observed in regenerating axons. This led the authors to propose that
regulation of RXRα was connected with processes related to axon
growth.
Asmentioned previously, a RAR has also recently been cloned from
the Lymnaea CNS (Carter and Spencer, 2009). We do not yet know
whether this receptor also exists outside the nucleus and thus cannot
rule out the possibility that the RXRmay be acting in conjunction with
the RAR to produce growth cone turning. We also have not yet
determined whether the endogenous retinoid isomers might be
activating other parallel pathways (such as direct interactions with
enzymes) to produce growth cone turning, and so the exact
contribution of RXR activation in the turning response produced by
9-cis and atRA is yet to be determined.
A nongenomic role for RXR in growth cone turning
A signiﬁcant ﬁnding of our current study is that the RXR agonist
also produced growth cone turning of isolated growth cones, in the
absence of the cell body and nucleus, suggesting a novel, nongenomic
role in growth cone steering. There are a number of reports in the
literature of RA exerting nongenomic actions. Some of these involve
activation of messengers such as ERK1/2 and RSK (Aggarwal et al.,2006) and direct binding with PKC (Ochoa et al., 2003). Other reports
implicate nongenomic actions of RARs. For example, RA rapidly
enhanced spontaneous acetylcholine release at developing neuro-
muscular synapses in Xenopus cell culture and an RARβ agonist alone
mimicked this effect (Liao et al., 2004). Another study demonstrated
RARα in rat hippocampal dendrites and demonstrated a nongenomic
role in the translational control of GluR1 (Poon and Chen, 2008). The
activation of phosphatidylinositol-3-kinase during RA-induced differ-
entiation of neuroblastoma cells is also proposed to occur via
nongenomic actions of the RAR (Masia et al., 2007). Although there
are no previous reports of nongenomic actions of RXR in the CNS,
RXRs were recently shown to exert nongenomic effects in human
platelets (Moraes et al., 2007). RXRα and RXRβ were present in the
cytosolic and membrane fractions of the platelets, and (despite the
lack of a nucleus) the proposed RXR ligand, 9-cis RA, inhibited platelet
aggregation. It was determined that the platelet RXR bound to the G
protein Gq/11 and that this associationwas strengthenedwithin 3 min
of 9-cis RA stimulation. This led the authors to propose that the RXR–
Gq/11 binding event induced by 9-cis RA prevents Gq/11 from
activating Rac and the subsequent aggregation-dependant pathways
(Moraes et al., 2007). Although we have previously shown a role for
protein synthesis and calcium inﬂux in the nongenomic actions of RA
in Lymnaea growth cone turning, where and how the RXR may be
involved in this signaling pathway are currently unknown.
In summary, we have cloned the ﬁrst retinoid receptor in the
mollusc L. stagnalis and demonstrated its presence and potential role
during embryonic development. Signiﬁcantly, we have demonstrated
a cytoplasmic and neuritic localization for LymRXR, both in non-
regenerating adult CNSs and in regenerating motor neurons in vitro.
Finally, we have shown that LymRXR is present in regenerating
growth cones and provide the ﬁrst evidence that RXR may play a
novel, nongenomic role in mediating the chemotropic effects of RA.Acknowledgments
This work was supported by Discovery Grants to G.E.S. and R.L.C.
from the Natural Sciences and Engineering Research Council (NSERC)
of Canada. C.J.C. and N.R.F. were supported by scholarships from
NSERC (Canada). We are very grateful to Dr. Hiroyuki Kagechika
(University of Tokyo, Japan) for the kind gift of the RXR agonist,
PA024, as well as the RXR antagonists, PA452 and HX531. We would
also like to thank Dr. Zhong-Ping Feng (University of Toronto, Canada)
for her assistance in reading the manuscript.References
Aggarwal, S., Kim, S.W., Cheon, K., Tabassam, F.H., Yoon, J.H., Koo, J.S., 2006. Nonclassical
action of retinoic acid on the activation of the cAMP response element-binding
protein in normal human bronchial epithelial cells. Mol. Biol. Cell 17, 566–575.
Albalat, R., Canestro, C., 2009. Identiﬁcation of Aldh1a, Cyp26 and RAR orthologs in
protostomes pushes back the retinoic acid genetic machinery in evolutionary time
to the bilaterian ancestor. Chem. Biol. Interact. 178, 188–196.
Bettinger, B.T., Gilbert, D.M., Amberg, D.C., 2004. Actin up in the nucleus. Nat. Rev. Mol.
Cell Biol. 5, 410–415.
Biesalski, H.K., Doepner, G., Tzimas, G., Gamulin, V., Schroder, H.C., Batel, R., Nau, H.,
Muller, W.E., 1992. Modulation ofmyb gene expression in sponges by retinoic acid.
Oncogene 7, 1765–1774.
Borel, F., de Groot, A., Juillan-Binard, C., de Rosny, E., Laudet, V., Pebay-Peyroula, E.,
Fontecilla-Camps, J.C., Ferrer, J.L., 2009. Crystal structure of the ligand-binding
domain of the retinoid X receptor from the ascidian Polyandrocarpa misakiensis.
Proteins 74, 538–542.
Bouton, D., Escriva, H., de Mendonca, R.L., Glineur, C., Bertin, B., Noel, C., Robinson-
Rechavi, M., de Groot, A., Cornette, J., Laudet, V., Pierce, R.J., 2005. A conserved
retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates
transcription in the presence of retinoids. J. Mol. Endocrinol. 34, 567–582.
Calderon, F., Kim, H.Y., 2007. Role of RXR in neurite outgrowth induced by
docosahexaenoic acid. Prostaglandins Leukot. Essent. Fatty Acids 77, 227–232.
Carter, C.J. and Spencer, G.E., 2009. Cloning of a retinoic acid receptor (RAR) from the
CNS of a non-chordate, invertebrate protostome and its role in embryonic
development. Program# 225.11, 2009 Neuroscience Meeting Planner. Washington,
DC: Society for Neuroscience. Online.
137C.J. Carter et al. / Developmental Biology 343 (2010) 124–137Chung, A.C., Durica, D.S., Clifton, S.W., Roe, B.A., Hopkins, P.M., 1998. Cloning of
crustacean ecdysteroid receptor and retinoid-X receptor gene homologs and
elevation of retinod-X receptor mRNA by retinoic acid. Mol. Cell. Endocrinol. 139,
209–227.
Corcoran, J., Shroot, B., Pizzey, J., Maden, M., 2000. The role of retinoic acid receptors in
neurite outgrowth from different populations of embryonic mouse dorsal root
ganglia. J. Cell Sci. 113 (Pt 14), 2567–2574.
Creton, R., Zwaan, G., Dohmen, R., 1993. Speciﬁc developmental defects in molluscs
after treatment with retinoic acid during gastrulation. Dev. Growth Differ. 35,
357–364.
DeFranco, D.B., 1997. Subnuclear trafﬁcking of steroid receptors. Biochem. Soc. Trans.
25, 592–597.
Dmetrichuk, J.M., Spencer, G.E., Carlone, R.L., 2005. Retinoic acid-dependent attraction
of adult spinal cord axons towards regenerating newt limb blastemas in vitro. Dev.
Biol. 281, 112–120.
Dmetrichuk, J.M., Carlone, R.L., Spencer, G.E., 2006. Retinoic acid induces neurite
outgrowth and growth cone turning in invertebrate neurons. Dev. Biol. 294, 39–49.
Dmetrichuk, J.M., Carlone, R.L., Jones, T.R., Vesprini, N.D., Spencer, G.E., 2008. Detection
of endogenous retinoids in the molluscan CNS and characterization of the trophic
and tropic actions of 9-cis retinoic acid on isolated neurons. J. Neurosci. 28,
13014–13024.
Durston, A.J., Timmermans, J.P., Hage, W.J., Hendriks, H.F., de Vries, N.J., Heideveld, M.,
Nieuwkoop, P.D., 1989. Retinoic acid causes an anteroposterior transformation in
the developing central nervous system. Nature 340, 140–144.
Egea, P.F., Mitschler, A., Rochel, N., Ruff, M., Chambon, P., Moras, D., 2000. Crystal
structure of the human RXRalpha ligand-binding domain bound to its natural
ligand: 9-cis retinoic acid. EMBO J. 19, 2592–2601.
Farrar, N.R., Dmetrichuk, J.M., Carlone, R.L., Spencer, G.E., 2009. A novel, nongenomic
mechanism underlies retinoic acid-induced growth cone turning. J. Neurosci. 29,
14136–14142.
Franke,W.W., 2004. Actin's many actions start at the genes. Nat. Cell Biol. 6, 1013–1014.
Gu, P.L., Gunawardene, Y.I., Chow, B.C., He, J.G., Chan, S.M., 2002. Characterization of a
novel cellular retinoic acid/retinol binding protein from shrimp: expression of the
recombinant protein for immunohistochemical detection and binding assay. Gene
288, 77–84.
Gudas, L.J., 1994. Retinoids and vertebrate development. J. Biol. Chem. 269,
15399–15402.
Heyman, R.A., Mangelsdorf, D.J., Dyck, J.A., Stein, R.B., Eichele, G., Evans, R.M., Thaller, C.,
1992. 9-cis Retinoic acid is a high afﬁnity ligand for the retinoid X receptor. Cell 68,
397–406.
Kaffman, A., O'Shea, E.K., 1999. Regulation of nuclear localization: a key to a door. Annu.
Rev. Cell Dev. Biol. 15, 291–339.
Kersten, S., Kelleher, D., Chambon, P., Gronemeyer, H., Noy, N., 1995. Retinoid X receptor
alpha forms tetramers in solution. Proc. Natl. Acad. Sci. U. S. A. 92, 8645–8649.
Knutson, D.C., Clagett-Dame, M., 2008. atRA Regulation of NEDD9, a gene involved in
neurite outgrowth and cell adhesion. Arch. Biochem. Biophys. 477, 163–174.
Kostrouch, Z., Kostrouchova, M., Love, W., Jannini, E., Piatigorsky, J., Rall, J.E., 1998.
Retinoic acid X receptor in the diploblast, Tripedalia cystophora. Proc. Natl. Acad. Sci.
U. S. A. 95, 13442–13447.
Liao, Y.P., Ho, S.Y., Liou, J.C., 2004. Non-genomic regulation of transmitter release by retinoic
acid at developing motoneurons in Xenopus cell culture. J. Cell Sci. 117, 2917–2924.
Lin, X.F., Zhao, B.X., Chen, H.Z., Ye, X.F., Yang, C.Y., Zhou, H.Y., Zhang, M.Q., Lin, S.C., Wu,
Q., 2004. RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-
dependent manner in gastric cancer cells. J. Cell Sci. 117, 5609–5621.
Lohof, A.M., Quillan, M., Dan, Y., Poo, M.M., 1992. Asymmetric modulation of cytosolic
cAMP activity induces growth cone turning. J. Neurosci. 12, 1253–1261.
Maden, M., 2007. Retinoic acid in the development, regeneration and maintenance of
the nervous system. Nat. Rev. Neurosci. 8, 755–765.
Maden, M., Hind, M., 2003. Retinoic acid, a regeneration-inducing molecule. Dev. Dyn.
226, 237–244.
Maden, M., Keen, G., Jones, G.E., 1998. Retinoic acid as a chemotactic molecule in
neuronal development. Int. J. Dev. Neurosci. 16, 317–322.Mangelsdorf, D.J., Borgmeyer, U., Heyman, R.A., Zhou, J.Y., Ong, E.S., Oro, A.E., Kakizuka,
A., Evans, R.M., 1992. Characterization of three RXR genes that mediate the action of
9-cis retinoic acid. Genes Dev. 6, 329–344.
Mansﬁeld, S.G., Cammer, S., Alexander, S.C., Muehleisen, D.P., Gray, R.S., Tropsha, A.,
Bollenbacher, W.E., 1998. Molecular cloning and characterization of an invertebrate
cellular retinoic acid binding protein. Proc. Natl. Acad. Sci. U. S. A. 95, 6825–6830.
Masia, S., Alvarez, S., de Lera, A.R., Barettino, D., 2007. Rapid, nongenomic actions of
retinoic acid on phospatidylinositol-3-kinase signaling pathway by the retinoic
acid receptor. Mol. Endocrinol. 21, 2391–2402.
Meshcheryakov, V.N., 1972. The common pond snail Lymnaea stagnalis. In: Dettlaff, T.A.,
Vassetzky, S.G. (Eds.), Animal Species for the Developmental Studies. Consultants
Bureau, New York, pp. 69–132.
Mey, J., McCaffery, P., 2004. Retinoic acid signaling in the nervous system of adult
vertebrates. Neuroscientist 10, 409–421.
Moraes, L.A., Swales, K.E., Wray, J.A., Damazo, A., Gibbins, J.M., Warner, T.D., Bishop-
Bailey, D., 2007. Nongenomic signaling of the retinoid X receptor through binding
and inhibiting Gq in human platelets. Blood 109, 3741–3744.
Muley, P.D., McNeill, E.M., Marzinke, M.A., Knobel, K.M., Barr, M.M., Clagett-Dame, M.,
2008. The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth
and axonal elongation. Dev. Neurobiol. 68, 1441–1453.
Nagy, T., Elekes, K., 2000. Embryogenesis of the central nervous system of the pond snail
Lymnaea stagnalis L. An ultrastructural study. J. Neurocytol. 29, 43–60.
Nowickyj, S.M., Chithalen, J.V., Cameron, D., Tyshenko, M.G., Petkovich, M., Wyatt, G.R.,
Jones, G., Walker, V.K., 2008. Locust retinoid X receptors: 9-cis-retinoic acid in
embryos from a primitive insect. Proc. Natl. Acad. Sci. U. S. A. 105, 9540–9545.
Ochoa,W.F., Torrecillas, A., Fita, I., Verdaguer, N., Corbalan-Garcia, S., Gomez-Fernandez,
J.C., 2003. Retinoic acid binds to the C2-domain of protein kinase C(alpha).
Biochemistry 42, 8774–8779.
Ohta, K., Kawachi, E., Inoue, N., Fukasawa, H., Hashimoto, Y., Itai, A., Kagechika, H., 2000.
Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in
retinobenzoic acids. Chem. Pharm. Bull. (Tokyo) 48, 1504–1513.
Poon, M.M., Chen, L., 2008. Retinoic acid-gated sequence-speciﬁc translational control
by RARalpha. Proc. Natl. Acad. Sci. U. S. A. 105, 20303–20308.
Ridgway, R.L., Syed, N.I., Lukowiak, K., Bulloch, A.G., 1991. Nerve growth factor (NGF)
induces sprouting of speciﬁc neurons of the snail, Lymnaea stagnalis. J. Neurobiol.
22, 377–390.
Schrage, K., Koopmans, G., Joosten, E.A., Mey, J., 2006. Macrophages and neurons are
targets of retinoic acid signaling after spinal cord contusion injury. Eur. J. Neurosci.
23, 285–295.
Sive, H.L., Draper, B.W., Harland, R.M.,Weintraub, H., 1990. Identiﬁcation of a retinoic acid-
sensitive period during primary axis formation in Xenopus laevis. Genes Dev. 4,
932–942.
Solomin, L., Johansson, C.B., Zetterstrom, R.H., Bissonnette, R.P., Heyman, R.A., Olson, L.,
Lendahl, U., Frisen, J., Perlmann, T., 1998. Retinoid-X receptor signalling in the
developing spinal cord. Nature 395, 398–402.
Spencer, G.E., Syed, N.I., van Kesteren, E., Lukowiak, K., Geraerts, W.P., van Minnen, J.,
2000. Synthesis and functional integration of a neurotransmitter receptor in
isolated invertebrate axons. J. Neurobiol. 44, 72–81.
Stratford, T., Horton, C., Maden, M., 1996. Retinoic acid is required for the initiation of
outgrowth in the chick limb bud. Curr. Biol. 6, 1124–1133.
Sun, K., Montana, V., Chellappa, K., Brelivet, Y., Moras, D., Maeda, Y., Parpura, V., Paschal,
B.M., Sladek, F.M., 2007. Phosphorylation of a conserved serine in the deoxyr-
ibonucleic acid binding domain of nuclear receptors alters intracellular localization.
Mol. Endocrinol. 21, 1297–1311.
Wiens, M., Batel, R., Korzhev, M., Muller, W.E., 2003. Retinoid X receptor and retinoic acid
response in the marine sponge Suberites domuncula. J. Exp. Biol. 206, 3261–3271.
Wong, R.G., Hadley, R.D., Kater, S.B., Hauser, G.C., 1981. Neurite outgrowth in molluscan
organ and cell cultures: the role of conditioning factor(s). J. Neurosci. 1, 1008–1021.
Wuarin, L., Sidell, N., de Vellis, J., 1990. Retinoids increase perinatal spinal cord neuronal
survival and astroglial differentiation. Int. J. Dev. Neurosci. 8, 317–326.
Zhelyaznik, N., Mey, J., 2006. Regulation of retinoic acid receptors alpha, beta and
retinoid X receptor alpha after sciatic nerve injury. Neuroscience 141, 1761–1774.
